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ABSTRACT
Traumatic brain injuries (TBIs) have become a focal point for discussion in the
media today. They are an unfortunate part of many recreational activities and military
participation. The long-term effects of concussions and other types of mild traumatic
brain injury (mTBI) are becoming increasingly evident. It appears that they can
contribute to the development of certain neurodegenerative diseases later in life, and of
particular interest is chronic traumatic encephalopathy (CTE). CTE is a progressive
tauopathy characterized by a variety of cognitive and behavioral changes, which is
correlated with a history of repetitive brain trauma. This thesis provides a review of the
pertinent literature in attempt to link the development of CTE to the neurophysiological
changes associated with concussions and mTBI by providing an in-depth analysis of both
concussions and CTE. However, even with the current evidence, prospective studies will
be necessary to gain a better understanding of the disorder.
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11. Introduction
Recently, traumatic brain injury (TBI) has garnered a lot of attention in the media
with reports of professional athletes experiencing detrimental outcomes as a result of
repeated head injuries by their participation in contact sports [1, 2]. Of particular interest
are concussions, a type of mild traumatic brain injury (mTBI), and their long-term impact
in developing the neurodegenerative disorder, chronic traumatic encephalopathy (CTE)
[3]. CTE is a progressive tauopathy characterized by widespread neurodegeneration that
has been linked to a considerable variety of cognitive deficits and behavioral changes.
Thus far, it has only been diagnosed neuropathologically in those with a history of
repetitive TBI post-mortem. Therefore, CTE is believed to be caused, in large part, by
TBI that can occur as a result of contact sports, military participation, and other
recreational activities [4, 5].
This thesis will provide a comprehensive review and analysis of the recent
literature regarding CTE and will attempt to attribute the pathological changes associated
with mTBI towards the development of the disorder. In order to do so, the relevant
background information regarding concussions and mTBI will be reviewed. This
discussion will include the biomechanics and pathophysiology of injury, the clinical signs
and symptoms of concussion, and the currently available testing and treatment guidelines.
It will then detail CTE, including the clinical/neuropathological presentations, the disease
course, risk factors, potential clinical diagnostic evaluations, and treatment/preventive
measures.
22. Concussion
The word, concussion, is derived from the Latin “concutere,” which means “to
dash together” or “to shake violently” [6]. Concussion is a complex pathophysiological
process that occurs as a result of a direct or indirect external forces transmitted to the
head, which can lead to a collision between the brain and surrounding structures or put
excessive strain on brain tissue or cerebrovasculature. These events may or may not result
in loss of consciousness (LOC) [7, 8]. The pattern and extent of the resulting damage is
determined by the duration, intensity, and direction of these forces [9]. Concussions
result in short-term neurologic impairment that presents with a variety of clinical
symptoms, which typically resolve spontaneously [8].
As stated previously, concussions are a type of mTBI. TBIs are divided into
categories of mild, moderate, and severe and are clinically diagnosed based upon the
criteria presented in Table 1 below [10].
Table 1. TBI Stratification.
Current clinical diagnostic criteria to determine TBI severity in patient post-injury. Patient is
assigned severity if he/she meets one or more of the below criteria within a category. LOC – Loss
of consciousness; AOC – Alteration of consciousness/mental state; PTA – Post-traumatic
amnesia; GCS – Glasgow Coma Scale. (Table taken from [10]).
3The terms “concussion” and “mTBI” are often, mistakenly, used interchangeably by the
scientific community [8]. All concussions are mTBIs, but not all mTBIs are concussions.
Concussions fall on the less-severe end of the spectrum of mTBIs, and thus, represent
only a subset of the category [11].
An estimated 1.4-3.8 million TBIs occur in the United States annually, with
mTBIs accounting for approximately 70-90% of all cases [12–14]. These incidences
include approximately 1.1 million visits to the emergency department, 235,000
hospitalizations, and result in approximately 50,000 deaths every year. However, the
actual number of mTBIs is most likely higher because many go unreported or are never
diagnosed [13]. The leading causes of mTBIs are motor vehicle accidents (MVA),
sporting activities, and falls among adults. Falls, sporting activities, and pedestrian
injuries represent the largest proportion among children (Figure 1) [15].
Figure 1. Epidemiology of mTBI.
The average prevalence of particular mechanisms of injury taken from multiple studies in (a)
adults and (b) children. Values are modified to sum to 100%, and ranges for specific mechanisms
are located in the legend. (Figure taken from [15]).
4The Centers for Disease Control and Prevention (CDC) estimate that 300,000
sports-related concussions occur every year, and their rates are continually on the rise
[16, 17]. This rise could be due to an increase in actual occurrence or improved
concussion education and incidence reporting. Repetitive closed head injuries, which can
result in concussion, occur in a considerable variety of contact sports, including football,
rugby, wrestling, soccer, boxing, lacrosse, hockey, and skiing [4]. With a great proportion
of America’s youth participating in these sports on a regular basis, there is significant
concern regarding the effects of concussion.
Several researchers have suggested that there may be a critical window of 7-10
days post-injury in which there is an increased likelihood of repeat concussion, which
may have a major impact on return-to-play guidelines following sport-related concussion.
Two studies examining concussion incidence in collegiate football players found that
well over 75% of repeat concussions occurred within 10 days of the first injury [18, 19].
In attempts to better understand the effects of these TBIs, animal models have been used
to simulate concussions in humans. Rodents subjected to a second mTBI within 24 hours
of the initial injury displayed impaired memory performance, decreased astrocytic
activity, and axonal injury compared to those animals with only a single injury [20]. In
another model, the time of second mTBI was delayed to 3, 5, or 7 days post-injury. Those
animals subjected to a second injury on the third or fifth days exhibited significantly
impaired cognitive function, while animals reinjured a week later showed no significant
cognitive deficits; thereby, supporting the idea of critical period of increased post-
concussive vulnerability [21].
5However, while many repeat concussions tend to occur within this critical
window, this increased susceptibility may extend well beyond the first week. During one
season of Canadian professional football, players who sustained a single concussion were
over 5 times more likely to be diagnosed with a second that same season compared to
players with no history of concussion [22]. Collegiate football players with a reported
history of, at least, 3 concussions were, also, 3 times more likely to sustain an additional
concussion during their career compared to their counterparts with no concussion history
[18]. This could be due to genetic predisposition, or there may be long-term
neuropathological consequences of even a single concussion.
There is, also, data that shows that athletes who suffer multiple concussions
require longer recovery times. A study looking at high school athletes found there to be
statistically significant enduring neuropsychological effects in subjects with a history of
two or more concussions [23]. Another study found that athletes with a multiple
concussion history performed significantly lower on memory tests 2 days following
injury than those who had sustained only their first concussion [24]. Balance deficits
have, also, been shown to require longer recovery times in athletes experiencing their
second concussion [25]. Therefore, it appears that there are more long-term effects from
sustaining even a single concussion.
2.1 Biomechanics
A concussion results from traumatic forces imparted on the brain induced by rapid
acceleration or deceleration. The major mechanisms of brain injury are positive pressure,
6negative pressure, and/or shear strain [26]. Positive pressure is developed at the site of
impact, or the coup site, while negative pressure is created at the countrecoup site (Figure
2).
Figure 2. Biomechanics of Concussion.
A force is exerted on the brain that causes it to move within skull and impact surrounding
structures. The figure illustrates both the coup site and countrecoup site. (Figure modified from
[27]).
Deformation of the skull further accentuates these pressures at both sites. Positive
pressure forces the skull to bend outward, while negative pressure pulls the skull inward.
Positive pressure can result in brain contusion, whereas negative pressure may injure the
brain by tensile loading or cavitation. Cavitation is the compressive loading that occurs
7due to the collapse of vapor bubbles that are initially formed under negative pressure
[28]. Lastly, shear strain elongates or stretches axons and blood vessels, which can result
in diffuse axonal injury (DAI), affecting the white matter tracts of the brain [28, 29].
However, axons are not physically sheared at time of injury except during severe
occurrences [4].
Rotational forces are believed to be of primary importance in producing
concussion [30–32]. Brain motion is more pronounced with a large rotational acceleration
vector, and it produces 90% of total strain [28, 33]. However, one National Football
League (NFL) study found linear acceleration to be more highly correlated with
concussive injury [34]. Thus, more research is necessary to elucidate exactly the types of
forces important in concussive injury.
Several studies have attempted to quantify the necessary concussive threshold
levels for linear and rotational acceleration by using kinematics data from football players
[34–36]. However, their results are conflicting. There were, also, some athletes who
received hits that exceeded their defined thresholds, yet did not sustain concussions.
Hence, the level of force exerted on the brain appears to be only one associated risk
factor for concussion.
2.2 Pathophysiology
It is the widely held belief of many neuropsychological and clinical researchers in
the field that concussions produce transient neurophysiological dysfunction, but do not
result in chronic neuropathologies [8, 37]. This idea is based largely on clinical
8evaluations of the restoration of cognitive functioning in individuals. It is further
complicated by the fact that the prevailing industry standards for brain imaging,
computed tomography (CT) and magnetic resonance imaging (MRI) scans, are frequently
normal due to the lack of macrostructural abnormalities [38, 39]. Yet, there is increasing
evidence that neurons are potentially irreversibly harmed by concussion.
In recent years, studies have indicated that there exists an intricate complex of
neurometabolic cascades, neurophysiological impairment, and cerebrovascular
dysfunction as a result of biomechanical forces responsible for concussion [7, 40, 41].
Many of these changes can be identified within minutes of injury and last for hours to
days, resulting in cell death and/or secondary axotomy in less than 24 hours (Figure 3)
[40, 42].
Figure 3. Post-Concussive Neurometabolic Cascade.
Metabolic cascade following experimental concussion. The large increase in Ca2+ release along
with the long-term changes observed in oxidative glucose metabolism (CMRgluc) and cerebral
blood flow (CBF) may be partly responsible for the critical period of increased vulnerability
following concussion. (Figure taken from [40]).
9TBI-associated neurodegeneration can either be due to direct, physical damage or
secondary injuries, involving diffuse, delayed mechanisms, such as, ion dysregulation,
excitotoxicity, the neuroinflammatory response, apoptotic/necrotic cascades, and
ischemic injury [27, 43, 44]. Many of these mechanisms are highlighted in Figure 4
below.
Figure 4. Neuromembrane Events in TBI.
TBI sets into motion a cascade of events that result in ion dysregulation, mitochondrial damage,
and ultimately, cell death. BBB – Blood-brain barrier; CBF – Cerebral blood flow; CBV –
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Cerebral blood volume; CPP – Cerebral pulse pressure; ICP – Intracranial pressure. (Figure taken
from [45]).
The following subsections will detail each potential neurodegenerative mechanism of
concussion. Any or all of the following may be occurring to varying degrees depending
on the severity of the injury.
2.2.1 Diffuse Axonal Injury
DAI is one of the most frequently documented pathological findings of TBI [27].
The shear strains created by the traumatic biomechanical forces of concussion can stretch
axons, resulting in axolemmal compromise of the cortical and subcortical white matter
[28, 29]. Axons are commonly damaged when they are required to change direction due
to the presence of blood vessels, to enter target nuclei, or when decussation occurs [46–
50]. Thicker neurons are typically more affected, and axonal injury is often identified
where changes in tissue density occur [47, 49–52].
Axons can either be injured by direct shearing or by secondary axotomy, which
occurs over hours or days [53]. Axons are rarely injured as a result of primary injury in
cases of concussion [4]. Hence, the majority of DAI occurs by way of a pathophysiologic
process that results in the dismantling of microtubules and axonal cytoskeleton [47, 50,
54–58].
Elongation of the axon during concussive injury increases axolemmal
permeability by causing certain sodium channels at the nodes of Ranvier to become
leaky, resulting in a large influx of sodium and calcium ions and cell membrane
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hyperpolarization [59]. This uncontrolled influx of calcium produces microtubule
disruption, calpain and caspase release, mitochondrial swelling, and impairment of
axonal transport that leads to axonal swelling and ultimately, secondary axotomy [40, 42,
60–62]. Rapid axonal swelling, Wallerian degeneration, and perisomatic axotomy may
also occur without alterations in axolemmal permeability [4].
Elevated axoplasmic levels of free calcium result in spontaneous
depolymerization of microtubules and trigger activation of calcium-sensitive neutral
proteases, or calpains. Calpains initiate neurofilament proteolysis and disrupt the
subaxolemmal cytoskeleton. This process causes the axolemma to become detached from
the axonal cytoskeleton and produces nodal blebs (Figure 5) [63, 64].
Figure 5. Cytoskeletal Disruption at Nodes of Ranvier.
Electron micrographs displaying transverse thin sections of nodes of Ranvier following stretch
injury in experimental animals. Control animal (a) shows abundant microtubules (arrows) and
neurofilaments at node. Section b shows no microtubules and very few neurofilaments
(arrowheads) in injured animal 15 minutes post-injury. After 1 hour (c) in injured animal,
subaxolemmal density is decreased and nodal bleb is evident. Original magnification × 54,000.
(Figure taken from [45]).
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Increased axoplasmic calcium, also, results in mitochondrial damage. In an
attempt to maintain axonal homeostasis, mitochondria sequester excess calcium, which
ultimately, reaches toxic levels. This process results in mitochondrial swelling and
interferes with oxidative phosphorylation [65]. Decreased adenosine triphosphate (ATP)
production leads to failure of the membrane-associated calcium-ATPase pumps and
further increases in axoplasmic calcium; thus, exacerbating the issue (Figure 6) [45].
Disruption of calcium homeostasis has been noted for up to a month following TBI in
experimental animals [66].
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Figure 6. Mitochondrial and Ca2+-ATPase Dysfunction.
Electron micrographs displaying longitudinal thin internodal (a-b) and nodal (c-d) sections 2
hours after stretch injury in experimental animals. Section a shows translucent mitochondria with
little trace of inner mitochondrial membranes. A lone mitochondrion (b) appears swollen and is
densely stained for calcium using pyroantimonate technique. An uninjured control animal (c)
exhibits dense staining for Ca2+-ATPase activity at node, whereas, there is little activity in an
injured animal 2 hours after injury (d). Original magnification: a = ×10,230; b = 15,421;
c = 12,780; d = 13, 270. (Figure taken from [45]).
Immunocytochemical evidence of axonal injury is identified within the first 2
hours of injury [67]. In humans, cytoskeletal disintegration is witnessed between 4-6
14
hours post-injury. Eventually, these pathophysiologic changes produce secondary
axotomy. Secondary axotomy typically begins 12 hours following injury and peaks 1-3
days later, with the resulting damage potentially lasting for years [30, 68, 69].
2.2.2 Excitotoxicity
Excitiotoxicity is the process by which neurons are damaged and killed from
excessive release of excitatory neurotransmitters, particularly glutamate (GLU). GLU is
the most common neurotransmitter found in the brain and is largely liberated from
astrocytes and microglia [27]. There is supportive evidence for a mass acute
accumulation of GLU and other excitatory neurotransmitters within the central nervous
system (CNS) following TBI [70–72]. GLU acts on neurons by stimulating ionotropic
receptors, such as, N-methyl-D-aspartate (NMDA), α-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate (AMPA), and kainate receptors, which regulate sodium and calcium
channels [27]. Increased stimulation of these receptors can lead to a host of reactions
within the cell.
Excitotoxicity has been found to coincide with calcium dysregulation,
mitochondrial impairment, microtubule dysfunction, membrane compromise, dendritic
retraction, synaptic loss, and apoptosis. Excessive GLU release can generate large
amounts of reactive oxygen species (ROS) and reactive nitrogen species (RNS), lipid
peroxidation products (LPPs), prostaglandins, and nitric oxide (NO); all of which, can be
harmful to the cell at high levels [27]. NO is particularly detrimental to cellular health by
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competing with oxygen for cytochrome oxidase within mitochondria, and thereby,
disrupting oxidative phosphorylation [73, 74].
2.2.3 Microglial Activation and the Neuroinflammatory Response
Microglia are known to be primed and/or activated due to disturbances in brain
homeostasis, including TBI [75–77]. Microglia are the resident macrophages of the CNS,
and thus, serve as an integral component of the innate immune system. They migrate into
the CNS and assume a “resting” morphological phenotype [78]. When microglia first
detect signs of nervous system dysfunction, they can adopt a primed state, in which they
do not discharge any reactive molecules. However, once primed, any subsequent
stimulation activates microglia to release large amounts of cytokines, chemokines,
interferons, LPPs, ROS/RNS, prostaglandins, and excitotoxins [76, 79–81]. Cytokines,
chemokines, and interferons recruit more immune-mediated cells to the site and result in
further inflammation. These activated microglia are hyper-reactive as a result of priming,
which causes them to release much higher levels of these molecules than normal [80].
Recent studies have found that microglial priming may exist for extended periods,
from months to even years [77, 82, 83]. With each incidence of TBI, there is increased
likelihood that this microglial priming and/or activation will be prolonged, resulting in
further neuroinflammation [27]. This can produce a continued, low grade loss of neurons
over the years.
2.2.4 Cerebrovascular Dysfunction
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Cerebral blood flow (CBF) is known to decrease following TBI due to
impairment of cerebral autoregulation [84]. However, the brain requires additional
oxygen and glucose immediately following TBI due to the increased activity of ATP-
dependent membrane pumps [39, 85]. This leads to a condition known as “concussion
penumbra,” which is similar to ischemic penumbra following a cerebrovascular accident
[86]. When metabolic demand can no longer be met, this process results in ischemic
injury to the brain.
2.3 Acute Clinical Signs/Symptoms
Concussions present with a rapid onset of clinical signs and symptoms, which
typically resolve spontaneously. However, no two concussions have similar presentations
or identical outcomes [87]. Occasionally, the appearance of symptoms might be delayed
until several hours after injury. Concussions may or may not involve LOC [8]. LOC only
occurs in around 15% of all cases, and it is not a reliable predictor of total injury severity
[13, 88, 89]. Concussions may, also, be accompanied by variety of motor phenomena,
such as, convulsive movements [8].
Those who sustain a concussion can complain of a constellation of clinical
symptoms. There are several somatic symptoms, including headaches, fatigue, dizziness,
nausea, sleep abnormalities, noise/light sensitivity, and other visual problems. Common
emotional symptoms comprise irritability, anxiety, and depression. Lastly, cognitive
symptoms include attention deficits, memory dysfunction, and decreased processing
speed (Figure 7) [90].
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Figure 7. Prevalence of Acute Concussion Symptoms.
18
Prevalence (%) of acute somatic (a), emotional (b), and cognitive (c) symptoms based upon the
findings of multiple studies. Error bars denote prevalence range across these studies. Stars
indicate that the results were taken from a single study. (Figure taken from [15]).
Symptoms can resolve within a matter of days, weeks, or months [91]. Several
studies have attempted to quantify the length of time it takes for individual symptoms to
resolve, and they found that the majority typically improve within a week [92–94]. The
resolution of these symptoms often follows a sequential course [8]. However, if
symptoms linger, the patient will be diagnosed with post-concussion syndrome (PCS)
[91].
2.4 Post-Concussion Syndrome
PCS is a complex, multifactorial disorder, and there is little consensus from the
scientific community on how to define or diagnose the condition [95]. There are two
major diagnostic systems for PCS, the International Classification of Diseases, 10th
Revision (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition, Text Revised (DSM-IV-TR) [96, 97]. Each system is defined in Figures 8 and 9,
respectively, and Figure 10 displays the prevalence of these symptoms below.
19
Figure 8. ICD-10 Classification of PCS.
Symptoms must be present in 3 or more symptom categories within 1 month of injury. (Figure
modified from [98]).
Figure 9. DSM-IV-TR Classification of PCS.
Symptoms must be present in 3 or more symptom categories, at least, 3 months following injury
with evidence of neuropsychological dysfunction. (Figure modified from [98]).
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Figure 10. Prevalence of Post-Concussion Symptoms.
Prevalence (%) of chronic somatic (a), emotional (b), and cognitive (c) symptoms 3 months
following injury based upon the findings of numerous studies. Error bars denote prevalence range
21
across these studies. Stars indicate that the results were taken from a single study. (Figure taken
from [15]).
Whether PCS is experienced following injury is dependent on a number of
factors, including post-injury psychological adjustment, pathophysiology, and congenital
vulnerability [99]. One study found that those who possessed a more negative outlook on
their injury were significantly more likely to suffer from symptoms of PCS after 3
months. In fact, this negative perception of injury severity by the subject was more
predictive of PCS than were the total number of acute symptoms reported immediately
following concussion [95]. Only 7-15% of people still experience any symptoms of PCS
one year after injury [91].
2.5 Testing
Concussion is typically diagnosed based upon the clinical and cognitive
symptoms reported by the patient, which can be non-specific and overlap with other
differential diagnoses [39, 100, 101]. There are a number of available diagnostic
checklists used in the field [39]. However, the most complete and widely used diagnostic
tool is the Sports Concussion Assessment Tool 2, developed at the 3rd International
Conference on Concussion [8]. Ideally, those who experience a concussion have had a
baseline evaluation prior to injury that includes a neuropsychiatric evaluation, cognitive
examination, and balance test, which can be repeated and results compared [102].
As previously mentioned, both CT and MRI imaging techniques typically fail to
find any gross neurological abnormalities [38, 39]. However, more sophisticated imaging
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techniques are being developed and implemented in concussion research, such as,
functional MRI, susceptibility-weighted imaging (SWI), diffusion tensor imaging (DTI),
magnetic resonance spectroscopy (MRS), and neurochemical biomarkers, which will be
detailed later in this review [103–106].
2.6 Treatment
Health professionals have been treating concussion using the same approach for
decades [38]. The pathophysiology behind the injury is often overlooked. However, since
no reliable measures of neurologic dysfunction currently exist, concussion treatment
focuses on the resolution of symptoms [107]. Those who have sustained a concussion
should be closely monitored for the first 24-48 hours, and any subsequent deterioration
should be immediately reported to a physician for evaluation. While recovering, the
patient should have complete physical and cognitive rest, as any increased workload
could exacerbate symptoms. Once symptoms have resolved and neuropsychiatric tests
appear normal, the patient may gradually increase activity. However, if any symptoms
reappear during this time, workload should again be decreased until activity can be
performed without issue [8].
3. Chronic Traumatic Encephalopathy
It has been known for some time that activities with a high degree of repetitive
head trauma, such as, certain contact sports, can increase the risk for neurodegenerative
diseases later in life, including Alzheimer’s disease (AD), Parkinson’s disease, and
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amyotrophic lateral sclerosis (ALS) [29, 108–110]. Although, a meta-analytic study
researching the association between TBI and AD could only find an correlation in men
[111]. There has been only one study in recent years that has actually used
neuropathologically-verified AD patients in researching this association, and it confirmed
this increased risk [112]. Since most of these studies only used clinical criteria to
diagnose AD, it is possible that a number of cases could have, in reality, been due to
CTE, alone or in combination with other neurodegenerative disorders [113, 114].
CTE is a neurodegenerative disease believed to be caused, in large part, by the
pathophysiological changes associated with repetitive brain trauma that can occur as a
result of contact sports, military participation, and other recreational activities [4, 5]. This
brain trauma can include mTBI, concussions, and even subconcussive injury [4, 29, 115,
116]. The symptoms of CTE include a variety of cognitive and behavioral deficits that do
not typically manifest until many years after the trauma-producing activity has ended [4,
29, 117]. While CTE may have overlapping clinical characteristics of other dementing
disorders, it is neuropathologically distinct from neurodegenerative diseases [4, 5]. The
risk of developing CTE probably varies by activity participation and exposure, sport
position, age, sex, genetic predisposition, and cognitive reserve [29].
3.1 History
In 1928, Martland first hypothesized that the repetitive brain trauma of
competitive boxing could result in cognitive and behavioral detriments. He introduced the
term, “punch drunk,” to characterize the spectrum of symptoms observed in these athletes
24
[118]. In the late 1930’s, Millspaugh detailed a set of motor and cognitive dysfunctions
seen in boxers, and alternatively, defined the condition as “dementia pugilistica” [119].
The term, CTE, was not coined until 1966 by Miller, and it was first described
neuropathologically in 1973, famously by Corsellis et al. [117, 120]. However, it was not
until recently that the disorder was attributed to more than just boxing. Contemporary
studies have neuropathologically diagnosed CTE in those who have participated in a
variety of other contact sports, as well as, military veterans, victims of physical abuse, a
self-injurer, an epileptic, and a circus clown who was shot from a human cannon [4, 116,
121–127].
Due to the present increased concern and awareness regarding the disorder, the
Center for the Study of Traumatic Encephalopathy was created in 2008 at the Boston
University School of Medicine, in collaboration with the Sports Legacy Institute [128].
The NFL, also, recently donated $30 million to the National Institutes of Health to help
fund brain injury research [129].
3.2 Clinical Presentation and Course
The clinical presentation of CTE is distinct from the acute and chronic sequelae of
concussion [121]. Symptoms do not usually manifest until long after the incidents of
repetitive brain trauma have concluded and the neurodegeneration is severe enough to
cause observable deficits [4, 29, 116, 117]. This delay of onset may be due to the effects
of the chronic neuropathological changes associated with mTBI [4]. However, it typically
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presents earlier than most other neurodegenerative diseases, like AD and frontotemporal
lobar degeneration [116].
The observed changes in both cognition and behavior found in CTE are reflective
of the neurodegeneration in brain regions most affected by the disease [130]. Early
neuropathological changes may not present clinically, but they become increasingly
obvious as the disease progresses [116].
3.2.1 Neuropsychological/Neuropsychiatric Changes
CTE can have effects on cognition, mood, and behavior in patients. Cognitive
changes include learning/memory impairment and executive dysfunction [130]. McKee et
al. identified memory impairment in greater than 60% of known cases [4]. Similar to AD,
CTE presents with anterograde amnesia, which is consistent with the observed
neurodegeneration of the hippocampus and associated medial temporal structures [131,
132]. The associated executive dysfunction is a result of frontal lobe atrophy found in
most cases [4].
Changes in mood include depression, irritability, apathy, and suicidality [130].
Any one of these mood changes has been reported in more than 60% of cases [4].
Depression is the most commonly identified symptom in those with a history of head
trauma [133]. These emotional changes are due to the neurodegeneration of the medial
temporal lobe and orbitofrontal regions seen in patients [121]. These changes can be
severe enough to result in a patient taking their own life [5].
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Lastly, behavioral alterations include disinhibition, poor impulse control,
increased aggression, and substance abuse [130]. The issues with disinhibition, impulse
control, and substance abuse most like stem from frontal lobe atrophy, while the
increased aggression is due to neuropathological changes seen in the limbic system [121,
134]. Unfortunately, the frequent substance abuse associated with the disease can
confound the presentation of clinical symptoms. These changes have, also, been linked to
homicidal behavior and drug and alcohol overdose in some [4, 5].
3.2.2 Neurological/Motor Changes
CTE frequently produces neurologic dysfunction, which can negatively impact
motor operations [130]. Signs of such impairment were found in approximately 40% of
subjects by McKee et al. and included Parkinsonism, dysphagia, slurred and dysarthric
speech, and ocular anomalies. The Parkinsonism arises from the atrophy of the substantia
nigra, cortical and subcortical frontal lobes, and/or cerebellum. The remaining symptoms
are a result of the neurodegeneration of brainstem nuclei [4].
A small subset of patients (11.8%) presented with a variant of the disorder, known
as chronic traumatic encephalomyelopathy (CTEM), that affects the spinal cord and is
associated with motor neuron disease, which clinically mimics ALS [5, 130, 135]. These
patients are more severely affected and display signs of progressive muscle atrophy,
balance and gait issues, fasciculations, and hyperactive deep tendon reflexes [135].
Typically, the onset of any cognitive and behavioral symptoms is seen several years after
the initial signs of motor neuron disease [5].
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3.2.3 Disease Progression
CTE has an insidious onset and gradual progression [29]. It frequently begins to
manifest between the ages of 30-50, at approximately 8 years following retirement for
professional athletes [4, 130]. This early presentation can help to distinguish it from other
neurodegenerative disorders. The disease progresses slowly, at a rate of 11-14 years
between the four separate pathological stages, which will be detailed below [5, 130].
However, in professional athletes, the disease course is much shorter, with a total mean
duration of 17.5 years [4]. As the disease advances, the symptoms become more severe
and numerous [116].
3.2.3.1 Stage I
During this very early stage of the disease, it is possible to not display any
symptoms. However, headache and attention deficits are the most common complaints.
Some patients, also, report short-term memory difficulties, depression, aggression,
explosivity, and executive dysfunction [5].
3.2.3.2 Stage II
The majority of individuals display some symptoms of CTE. These commonly
include depression, explosivity, attention deficits, headaches, and short-term memory
difficulties. Less frequently, patients complain of executive dysfunction, suicidality,
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impulsive behavior, and speech difficulties. A small subset of subjects have, also, been
diagnosed with the CTEM variant by McKee et al. by this stage [5].
3.2.3.3 Stage III
It is highly unlikely that patients will still be asymptomatic. Patients frequently
present with executive dysfunction, memory problems, explosivity, attention deficits,
depression, aggression, and visual abnormalities. Less common symptoms include
headaches, suicidality, apathy, and impulsive behavior. McKee et al. noted that
approximately 75% of subjects were considered to be cognitively impaired by this stage,
and a small portion developed symptoms of CTEM [5].
3.2.3.4 Stage IV
All are symptomatic and have developed varying degrees of dementia prior to this
point. The only symptoms not commonly observed in these patients are typically
dysarthria, impulsivity, and Parkinsonism [5].
3.3 Gross Pathology
As previously stated, CTE is pathologically distinct from other neurodegenerative
diseases [4, 5]. The disease presents with diffuse brain atrophy and a reduction in brain
weight [4]. The brain regions most severely affected are the cerebral cortex and medial
limbic structures [29, 116]. There is obvious degeneration of the thalamus, hypothalamus,
and mammillary bodies. Patients present with thinning of the corpus callosum and other
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subcortical white matter, as well as, pallor of the substantia nigra and locus coeruleus.
There is pronounced dilatation of the lateral and third ventricles along with anterior
cavum septum pellucidum and posterior septal fenestrations (Figure 11) [4]. Cavum
septum pellucidum is produced when the leaflets of the septum pellucidum are separated
by cerebrospinal fluid (CSF) [136]. This accumulation of CSF is likely caused by fluid
waves generated in the ventricles by repetitive brain trauma, which eventually, damage
the septum pellucidum [4, 29].
Figure 11. Gross Pathology of CTE.
Two coronal sections of human brain, control (top) and CTE-diagnosed brain (bottom). The
brain with CTE shows the characteristic dilatation of the lateral (1) and third (2) ventricles,
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cavum septum pellucidum (3), and atrophy of medial temporal lobe (4) and mammillary bodies
(5). (Figure taken from [116]).
3.3.1 Stage I
During this first stage of pathological development, there may be mild ventricular
enlargement. Other than that, there are relatively no gross abnormalities, and brain weight
is normal [5].
3.3.2 Stage II
Mild ventricular enlargement is more frequent with small cavum septum
pellucidum. There may, also, be pallor of the locus coeruleus and substantia nigra and
mammillary body atrophy. However, brain weight still remains approximately normal
[5].
3.3.3 Stage III
Most brains display ventricular dilatation and mild cerebral atrophy. Septal
abnormalities and pallor of the substantia nigra and locus coeruleus are found in close to
half of patients. Other common gross anatomic features include atrophy of thalamus and
mammillary bodies and thinning of the corpus callosum and subcortical white matter [5].
3.3.4 Stage IV
Ultimately, patients exhibit atrophy of cerebral cortex, medial temporal structures,
thalamus, hypothalamus, mammillary bodies, and white matter with significant
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ventricular enlargement and septal abnormalities. Pallor of the substantia nigra and locus
coeruleus is found in all cases. Brain weight is, also, significantly reduced by this point
[5].
3.3.5 Chronic Traumatic Encephalomyelopathy
In those small subset of patients diagnosed with the CTEM variant, there is
significant atrophy of the medullary pyramids and lateral corticospinal tracts. There is
extensive loss of cells in both the anterior horn and ventral roots [135].
3.4 Microscopic Pathology
The microscopic pathology of CTE is characterized by the accumulation of
hyperphosphorylated tau, transactive response deoxyribonucleic acid-binding protein 43
(TDP-43) inclusions, and in some cases, β-amyloid (Aβ) plaques affecting widespread
brain regions [4, 5, 135]. CTE morphogenesis likely initiates within the depths of sulci of
the cerebral cortex, often perivascularly, and slowly proliferates over the course of
decades to affect multiple other brain regions. Axonal varicosities and axonal loss are
present in all stages of CTE [5].
3.4.1 Tau
Under normal circumstances, the tau protein is predominately associated with
microtubules found in the axons of healthy CNS tissue, where it remains non-toxic [5].
However, hyperphosphorylation of intracellular tau causes it to become dissociated from
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microtubules. The increases in axoplasmic calcium and excitotoxicity associated with
TBI are known to activate specific kinases, which phosphorylate the tau protein; thus,
resulting in the dissociation from microtubules [137–140]. Once dissociated, tau is
susceptible to cleavage by calpains and caspases, misfolding, and aggregation. Excess
accumulation of tau aggregates, ultimately, results in neurodegeneration [29, 141–143].
TBI has been shown to lead to accumulation of hyperphosphorylated tau in the brain in
less than 24 hours of injury [144].
CTE is defined by the accumulation of hyperphosphorylated tau as neurofibrillary
tangles (NFTs), glial tangles (GTs), and spindle-shaped neurites. These are found
throughout the frontal, insular, and temporal cortices, as well as, the diencephalon, brain
stem, cerebellar dentate nucleus, and spinal cord [4].
NFTs and GTs are densely distributed within the hippocampus, entorhinal cortex,
amygdala, and olfactory bulbs, frequently in greater density compared to AD. There are,
also, profuse NFTs and GTs seen in the thalamus, hypothalamus, substantia nigra, locus
coeruleus, superior colliculus, medial geniculate, nucleus basalis of Meynert, medial
lemniscus, periaqueductal gray, dorsal and median raphe, oculomotor nucleus, trochlear
nucleus, trigeminal motor nucleus, ventral tegmental area, dorsal motor nucleus of the
vagus, pontine nuclei, inferior olives, hypoglossal nucleus, and reticular formation. The
nucleus accumbens is only moderately affected, and the caudate, putamen, and globus
pallidus are even less disturbed. The white matter tracts of the brainstem and spinal
display abundant GTs, especially perivascularly, and they are, also, present in subpial and
periventricular zones [4].
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Tau-immunoreactive neurites are found on astrocytes dispersed throughout
superficial neocortical layers. The corpus callosum and subcortical white matter, also,
possess several neurites [4]. Finally, NFTs, neurites, and GTs can be identified in the
dorsal and ventral horns of the spinal cord in patients with the CTEM variant [135].
CTE is distinguished from other tauopathies, like AD, by its uniquely irregular
deposition of NFTs, which predominately affects superficial neocortical layers (laminae
II/III) within the depths of sulci and surrounding microvasculature [4, 29, 145]. NFTs are
much more uniformly distributed in AD and found in laminae III/V [4]. This process in
CTE may initiate within these sulcal depths or surrounding small blood vessels and
spread via the internalization of tau aggregates by nearby cells. Once internalized, tau
aggregates might induce intracellular tau alterations much like prions [146]. Exactly why
the pathology first presents with the depths of sulci still remains a mystery. However, the
shear forces of repetitive TBI are more prone to damaging axons surrounding cerebral
microvasculature and associated vessels, and thus, explain the perivascular NFT and
neurite formation [123]. NFTs seen in CTE have higher levels of iron and aluminum
accumulation than AD, supporting the theory for perivascular formation [147].
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Figure 12. CTE Tau Pathology.
Top panel: Coronal hemisections of a control (left) and CTE-diagnosed brain (right) stained for
phosphorylated tau using AT8. The CTE-diagnosed brain shows extensive tau immunostaining
and neurodegeneration in the amygdala (a), entorhinal cortex (ec), temporal cortex (temp ctx),
insular cortex (ins), nucleus basalis of Meynert (nbM), and frontal cortex. Cortical changes are
more severe at sulcal depths. Bottom panels: (A) Dense NFT formation in depths of sulci (AT8).
(B) Subpial NFTs found in both neurons and astrocytes [AT8 (brown); GFAP (red)]. (C) Dense
NFT formation in CA1 of hippocampus (AT8). (D) NFTs and GTs found in subpial patches and
surrounding microvasculature (AT8). (E) NFT formation in laminae II/III (AT8). (F) NFT in
Betz cell of primary motor cortex (AT8). (G) Perivascular NFT deposition (AT8). Original
magnification: A = ×60; B = 350; C = 150; D = 150; E = 150; F = 350; G = 150. (Figure taken
from [116]).
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Much like AD, CTE pathology is composed of all 6 specific brain tau isoforms
[148]. NFTs are composed of comprised of both 3-repeat and 4-repeat tau. However, GTs
are primarily constructed of 4-repeat tau [5].
In contrast, the spindle-like shape of neurites is unique to CTE, and they are
believed to originate from axons [4, 149]. NFTs and GTs are, also, found in far greater
densities than other progressive tauopathies [29]. However, there have been a few
reported cases associated with neurodegeneration of the cerebral cortex, hippocampus,
and substantia nigra without any significant neurofibrillary pathology [4].
3.4.1.1 Stage I
There are focal epicenters of perivascular NFTs and GTs, predominantly within
the depths of sulci of the superior and dorsolateral frontal cortex. Small amounts of NFTs
are found in the locus coeruleus in a few cases. Axonal varicosities are present in the
frontal cortex, subcortical white matter, and in the white matter of the diencephalon [5].
3.4.1.2 Stage II
Hyperphosphorylated tau is prevalent as distinct foci in areas of the frontal,
temporal, parietal, insular, and septal cortices, with NFTs in the superficial layers of
cortex. NFTs are, also, present in the locus coeruleus, nucleus basalis of Meynert, and
amygdala in moderate densities. Lower densities of NFTs are observed in the thalamus,
hypothalamus, hippocampus, entorhinal cortex, substantia nigra, and dorsal and median
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raphe nuclei. Distorted axonal profiles are identified in the frontal and temporal cortices,
as well as, the white matter tracts [5].
3.4.1.3 Stage III
NFTs are widely dispersed throughout areas of the frontal, temporal, insular, and
septal cortices, as well as, the inferior parietal cortices. They are, also, observed in high
densities in the hypothalamus, hippocampus, amygdala, locus coeruleus, substantia nigra,
entorhinal cortex, olfactory bulbs, nucleus basalis of Meynert, mammillary bodies, and
dorsal and median raphe nuclei. NFTs can be identified in the thalamus, cingulate
cortices, dorsal motor nucleus of the vagus, nucleus accumbens, dentate nucleus of the
cerebellum, and the spinal cord only in small amounts. Distorted axonal varicosities and
axonal loss are prevalent in the subcortical white matter of the frontal and temporal
cortices [5].
3.4.1.4 Stage IV
Severe hyperphosphorylated tau pathologies are prevalent throughout the cerebral
cortex, diencephalon, basal ganglia, brainstem, and spinal cord. There is obvious axonal
loss in the subcortical white matter, as well as, the presence of axonal varicosities [5].
Figure 13 below shows the progression of the tau pathology.
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Figure 13. Tau Pathology Progression.
Left panel: Coronal hemisections of CTE-diagnosed brain show progression of tau pathology
from discrete foci in the depths of sulci in Stage I to more widespread accumulation by Stage IV.
Immunostained for tau using CP-13. Right panels: Display tau pathology progression in distinct
brain regions. Immunostained for tau using CP-13, and some counterstained with cresyl violet.
Scale bars = 100 µm. (Figure modified from [5]).
3.4.2 Transactive Response DNA-Binding Protein 43
TDP-43 is normally found within the nuclei of neurons and functions in
stabilizing and exporting the messenger ribonucleic acid transcript of neurofilaments. It is
critical in modulating the response to cytoskeletal injury within the cell, and its
expression is found to be upregulated following experimental axotomy in mice [150,
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151]. However, overexpression and dislocation from the nucleus to the cytoplasm are
correlated with cellular death [152–154]. Traumatic axonal injury associated with TBI
may potentially expedite cytoplasmic dislocation [29, 135].
TDP-43 inclusions are found in more than 80% of CTE cases and are most
commonly identified in subjects that present with a severe tau pathology [135]. It
accumulates as cytoplasmic and intranuclear inclusions in neurons and glia and as
neurites [4]. It is frequently observed in the frontal and medial temporal cortices,
diencephalon, thalamus, hypothalamus, hippocampus, amygdala, substantia nigra, insula,
caudate, putamen, brainstem, and subcortical white matter [116, 135].
In patients with CTEM, abundant TDP-43 inclusions are observed in the anterior
horn of the spinal cord and motor cortex [116, 135]. They present as neuronal, glial, and
neuritic inclusions in these cases [5].
3.4.2.1 Stage I
Some subjects present with TDP-43 neuritic inclusions in the subcortical white
matter of the frontal cortex and fornix [5].
3.4.2.2 Stage II
TDP-43 inclusions become more common in the medial temporal lobe, brainstem,
and subcortical white matter, frequently of subpial, periventricular, or perivascular
formation. However, it is possible to have more severe TDP-43 distribution as neuronal
and glial inclusions and neurites throughout the cerebral cortex, diencephalon, basal
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ganglia, brainstem, and spinal cord. CTEM patients show marked loss of lateral and
ventral corticospinal tracts and anterior horn cells [5].
3.4.2.3 Stage III
Most subjects have TDP-43-positive neurites in the cerebral cortex, medial
temporal lobe, or brainstem. Those with CTEM have much more severe and widespread
TDP-43 pathology, presenting with intraneuronal and intraglial inclusions and neurites
[5].
3.4.2.4 Stage IV
Ultimately, TDP-43 pathology becomes severe in majority of subjects with
neuronal and glial inclusions and neurites in the cerebral cortex, medial temporal lobe,
diencephalon, basal ganglia, and brainstem. They are typically less dense in spinal cord.
In those most severely affected, TDP-43 inclusions are observed in all layers of cortex
with sporadic inclusions in the hippocampus [5].
3.4.3 β-amyloid
Neurotoxic Aβ is a 42 residue peptide that is enzymatic cleaved from the
transmembrane protein, amyloid precursor protein (APP), by β-secretase and γ-secretase.
This form of Aβ is highly prone to misfolding and aggregation, resulting in insoluble
plaque formation. Excess accumulation of these plaques culminates in neurodegeneration
[155].
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APP is believed to have neurotrophic functions, which help axons recover after
damage [156–158]. APP is known to be upregulated in response to TBI, which can
potentially result in Aβ plaque formation in some patients within hours of injury [159–
162]. However, it is unknown how long increased levels of APP and Aβ exist for
following TBI [29].
The role of Aβ pathology in CTE is still unclear. It is found in only 40-45% of
those diagnosed with CTE, and typically, it is only observed in significantly older
patients. Of those cases, about half are diagnosed with another neurodegenerative
disorder in combination with CTE, and therefore, the neuropathological findings may be
confounded by the presence of multiple disorders. This contrasts with AD, in which a
severe Aβ pathology is identified in virtually all patients. When Aβ is present, there is a
primarily diffuse distribution of plaques with few neuritic plaques [4, 5].
3.5 Risk Factors
CTE has only been diagnosed neuropathologically in those with a history of
repetitive TBI. Therefore, TBI is considered to be a primary risk factor in CTE
pathogenesis, which can occur as a result of contact sports, military participation, and
other recreational activities. Of those diagnosed, greater than 90% have been athletes, yet
only a small sample of brains for those who participated in other trauma-producing
activities have been acquired for research [4, 5].
It is still unclear whether the severity and frequency of head trauma can affect the
risk of developing CTE [130]. A history of concussive injury appears to not be
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significantly correlated with the development of CTE [5]. The disorder has been
diagnosed in football players with no reported history of concussions, which suggests that
subconcussive brain trauma may be sufficient [4, 29]. There are measurable
neurophysiologic and cognitive impairments following subconcussive injury, yet they
typically go unnoticed and undiagnosed. As a result, many athletes will return to play too
early, potentially increasing their risk [163]. One study found there to be a significant
association between the number of hits sustained by football players and the ensuing
pathophysiological changes. However, the data is inconclusive due to the use of
regression analysis to determine this relationship [164].
Nevertheless, brain trauma appears to be necessary for CTE pathogenesis, yet it is
not entirely sufficient. There are several individuals with a history of repetitive TBI that
show no signs of the disorder upon examination [130]. There seem to be a number of
other factors involved, as well. The risk of developing CTE probably varies by activity
participation and exposure, sport position, age, sex, genetic predisposition, and cognitive
reserve; all of which, will be detailed below [29].
3.5.1 Sport
Repetitive head trauma occurs in a considerable variety of contact sports,
including football, boxing, rugby, wrestling, soccer, lacrosse, hockey, and skiing, and the
risk of developing CTE most likely varies across each sport and player position [4, 29].
Thus far, it has been neuropathologically diagnosed in athletes, who have participated in
football (50%), boxing (43%), hockey (4%), wrestling (2%), and soccer (1%). The
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disease appears to progress much more quickly in athletes compared to other subjects.
One-third of the diagnosed athletes were symptomatic by the time they retired, and up to
half experienced symptoms within 4 years [4, 5].
3.5.1.1 Football
CTE symptoms typically begin to present in early mid-life in retired football
players, and the disease shows an average duration of approximately 10 years prior to
death. However, symptoms have been identified in a player as young as 34, and another
player lived to be close to 100 years of age. The total number of years played, years since
retirement, and age at death are all significantly associated with the pathological stage of
CTE [4, 5].
In football, there are significant differences in the frequency and location of TBI
exposure based upon position [165, 166]. Players have been known to experience up to
nearly 1,400 impacts in a single season [165]. The defensive linemen receive the greatest
number of head impacts, followed by the offensive linemen, offensive skill players, and
lastly, defensive skill players [167]. Of those diagnosed with CTE, the majority are
offensive skill players, followed by offensive linemen, defensive skill players, and
defensive linemen. Thus, position played is not significantly correlated to the
pathological stage of CTE at time of death [5].
3.5.1.2 Boxing
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Historically, boxing has always been the most synonymous with CTE. Although,
on average, the disease progresses more slowly than in football players, with a mean
duration of approximately 20 years, and thus, boxers tend to live to an older age [4]. A
recent study reviewed the neuroimaging findings in boxers, and they discovered that
greater than 75% had, at least, one neuroanatomical abnormality that may be associated
with TBI. The severity of the injury was, also, associated with career length and total
number of fights [168]. However, a meta-analytic study found there to be no significant
correlation between boxing and CTE [169].
3.5.2 Military Service
Blast exposure is known to increase the risk for TBI in military veterans, and it
has been linked to those diagnosed with CTE [5, 170–173]. One study examined the
effects of explosive blasts on mice and found that it produces tau pathologies consistent
with CTE in as little as 2 weeks after injury [170]. Blast exposure may potentially induce
an inward skull flexure that generates enough positive pressure to damage the brain in
unhelmeted individuals [174]. However, cognitive and memory deficits are prevented by
head immobilization during blast exposure, suggesting that head acceleration is the most
likely mechanism of injury [170].
3.5.3 Age
The risk of CTE development based upon age of insult still remains unclear.
However, many athletes begin participating in their respective sports at a very young age
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[4]. There is significant evidence that concussion produces longer-lasting cognitive
impairment and prolonged pathogenesis in immature brains compared to adults [175,
176]. This could be due to a number of different characteristics, including incomplete
brain development, greater head-to-body ratio, and/or a thinner, more flexible skull [177,
178]. The developing brain is, also, more sensitive to the effects of excitotoxicity
following TBI, and the associated cerebral edema is more widespread and prolonged,
producing greater ischemic injury [86, 175, 178]. Therefore, TBI sustained at a young
age may, actually, hinder brain plasticity and development [179].
3.5.4 Sex
CTE has been predominantly diagnosed in males due to a much larger proportion
of male brain donations [130]. However, females may be at greater risk for concussions,
and they frequently take longer to recover than their male counterparts. This could be due
to better reporting by females, weaker upper body strength, and/or sex hormones [180,
181]. What role this plays in the development of CTE is unknown.
3.5.5 Genes
A gene of particular interest in CTE pathogenesis is the apolipoprotein E (APOE)
gene, as it is the strongest susceptibility gene for AD [130]. The APOE gene possesses 3
different alleles, APOE ε2, ε3, and ε4, which occur with a frequency of 7%, 78%, and
15%, respectively, in Caucasian populations [182]. The gene encodes for apolipoprotein
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E, which is believed to maintain microtubule integrity and assist in neural recovery
following injury [183].
Possession of the APOE ε4 allele is associated with more severe cognitive
impairments and longer recovery times following TBI [184–187]. However, one large
study saw no evidence of poor outcome 6 months following injury [188]. This allele may
reduce the brain’s capacity to repair itself after injury by affecting inflammatory
processes, cell proliferation, and cellular signaling [189]. APOE ε4 transgenic mice
exhibit increased neuroinflammation, glial activation, Aβ deposition, neurodegeneration,
and suffer greater mortality than controls following TBI [190, 191].
In a large study examining CTE, those diagnosed with the disorder showed no
proportional difference in APOE ε4 possession when compared to the general population
[5]. However, in a smaller sample, greater than 40% were shown to be APOE ε4 carriers,
a much higher number than the general population [135].
3.5.6 Cognitive Reserve
The timing of the onset of CTE symptoms may be affected by a patient’s
cognitive reserve. That is, an individual with a greater cognitive reserve might be able to
better mask the clinical symptoms of CTE than those with less cognitive reserve. This
may be accomplished by an enhanced ability to recruit or develop alternate neural
networks to compensate for the underlying neuropathology [192, 193]. Supporting this
theory, pre-injury intelligence quotient has been demonstrated to be a significant
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predictor of the severity of post-concussion symptoms for up to a year following injury
[194, 195].
3.6 Testing
Currently, there are no conclusive clinical diagnostic criteria for CTE. The
clinical presentation may be confounded by substance abuse or the presence of another
neuropsychiatric disorder. CTE can only be truly diagnosed neuropathologically post-
mortem, yet there is still no general consensus even on the neuropathologic criteria from
the scientific community [29, 130]. Fortunately, there has been a lot of progress made in
neurochemical biomarker development and neuroimaging, which may further assist in
diagnosing the disease in vivo.
3.6.1 Biomarkers
Presently, there are no neurochemical biomarkers available for CTE diagnosis [4].
However, tau levels in both plasma and CSF are currently being researched for
diagnosing AD, which may be applicable towards CTE diagnosis, as well [196–198].
Biomarkers are, also, being researched for diagnosis of concussion, including S100
calcium-binding protein B, neuron-specific enolase, and glial fibrillary acidic protein
[199, 200]. The confirmed neurochemical diagnosis of a concussion immediately
following injury may go a long way in preventing further injury, and ultimately, CTE.
3.6.2 Magnetic Resonance Imaging
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MRI makes use of magnetic fields and radio frequencies to detect alterations in
the spin signal of atoms, typically hydrogen atoms. It is frequently used to image the soft
tissues of the body and has much better resolution than CT [201]. Conventional MRI
imaging consists of a few different techniques that display various levels of contrast
among tissues, including T1-weighted, T2-weighted, and T2*-weighted (gradient echo)
sequences [202]. MRI is only capable of detecting some of the gross pathological
changes associated with CTE, such as, ventricular abnormalities and marked cortical
atrophy [4]. However, more sophisticated MRI techniques are being developed for
imaging the less discernible brain pathologies.
3.6.3 Susceptibility-Weighted Imaging
SWI makes use of MRI technology to distinguish susceptibility differences
among the structures and fluids within the body, such as, oxygenated versus
deoxygenated blood. It is capable of detecting microhemorrhagic lesions that cannot be
observed by traditional MRI [201]. Since the perivascular tau deposition associated with
CTE is believed to be triggered by the microvascular compromise observed with diffuse
axonal injury, SWI may be useful in differential diagnosis (Figure 14) [4, 121, 130].
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Figure 14. Microhemorrhagic Imaging.
CT (A) only finds a small focal point of microhemorrhages in the corpus callosum of child
following TBI. T2-weighted imaging (B) is not sensitive to hemorrhages, but it does show areas
of edema in the corpus callosum and peripheral hemispheres. T2*-weighted imaging (C) displays
some areas of microhemorrhage in the corpus callosum and peripheral hemispheres. SWI (D) is
by far the most sensitive to microhemorrhagic lesions; of which, it detects several throughout the
brain. (Figure taken from [202]).
3.6.4 Diffusion Tensor Imaging
DTI is another MRI-based technique that makes use of the diffusion properties of
water to distinguish microstructural tissue anatomy. It is capable of visualizing damage
within the white matter tracts of the brain [201]. White matter damage is a hallmark of
the DAI associated with mTBI, and it may be a mechanism in CTE pathogenesis [130,
203–205]. DTI was used in a small pilot study to examine the white matter integrity in
athletes displaying signs of CTE, and it showed a thinning of the corpus callosum (Figure
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15) [121]. DTI abnormalities are positively correlated with greater cognitive detriments
in humans and are predictive of long-term outcomes in rats following TBI [206–208].
However, there is a lack of uniformity for DTI protocols, which decreases the reliability
of data across multiple studies [209].
Figure 15. DTI in Athlete with CTE-Like Symptoms.
Former athlete presenting with CTE-like symptoms (left) and control (right). The top panels
show an obvious thinning of the corpus callosum in the center of the brain in the athlete (red).
The bottom panels use streamline tractography to trace the corpus callosum fiber bundle, and
once again, the fibers are much less numerous in the athlete compared to the control. (Figure
taken from [121]).
3.6.5 Magnetic Resonance Spectroscopy
MRS uses MRI-technology to measure the brain’s biochemical metabolites in
vivo. Metabolite concentrations can be used to provide neurophysiological data on
structural damage, neurotransmission, and several other brain functions [201]. MRS
frequently measures such metabolites as, N-acetylaspartate, choline, GLU, and creatine-
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phosphate [210–213]. Significant changes in concentration have been observed with each
following TBI, which may be predictive of long-term outcome [213–216]. If there are
chemical imbalances within the brain due to CTE, this imaging technique will be able to
detect them. As with DTI, there are significant differences among MRS protocols, which
can make results difficult to compare across multiple studies [38].
3.6.6 Positron Emission Tomography
Positron emission tomography (PET) uses radiolabeled isotopes to determine
areas of uptake or binding within the brain, which can provide information on brain
activity or chemical density [201]. A pilot study made use of a ligand developed for AD,
which chemically binds to both tau and Aβ, in an attempt to detect CTE in former NFL
players with symptoms of the disorder. They discovered characteristic deposits in areas
associated with CTE, but the data may be confounded by Aβ binding (Figure 16) [217].
A tau-selective ligand would be useful in CTE diagnosis, but there are none currently
available [130]. However, one team is already in the process of developing and
researching a tau-selective ligand [218].
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Figure 16. PET of Athletes with CTE-Like Symptoms.
Coronal and transaxial scans of 5 retired, symptomatic NFL players and a control. The players’
scans display consistently high signals in the amygdala and subcortical regions, which may be
indicative of the presence of CTE pathology. (Figure taken from [217]).
3.6.7 Single-Photon Emission Computed Tomography
Single-photon emission computed tomography (SPECT) uses radiolabeled tracers
to determine the distribution of cerebral blood flow. This can be used to detect
abnormalities in brain function, which could be useful in assisting in the diagnosis of
CTE [130, 219]. However, the specificity of this technique is poor, making a differential
diagnosis difficult [220].
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3.7 Treatment/Prevention
There are no treatments currently available for CTE [121]. However, since the
disease appears to have a long latency period prior to symptom development, there is a
large window of opportunity for potential therapies to slow or even stop the
neurodegenerative disease progression [135].
Since TBI is a primary risk factor in CTE pathogenesis, the most obvious way to
prevent disease development is to avoid head trauma and any activity that might increase
the risk for head injury. However, it is likely that many people will still engage in these
precarious activities regardless of the consequences, and thus, it is important to make
them safer. Protective equipment is often used to minimize the possibility of injury, but
unfortunately, there is no significant evidence that the currently available protective gear,
such as, helmets and mouth guards, will prevent concussive injury [8]. In fact, the very
use of this protective equipment may actually increase the risk for TBI by encouraging
more hazardous behavior [221]. Rule changes in sports may be necessary to decrease TBI
incidence and unnecessary contact in order to minimize risk [8].
Proper concussion diagnosis and management may, also, go a long way in
preventing CTE [29]. Removing individuals from any dangerous activity during the post-
injury vulnerability period will prevent any further damage. The CDC recently initiated
the Heads Up program, in an attempt, to better educate medical professionals and others
associated with youth athletics, primarily football, on concussion identification and
management [222]. Prudent return-to-play guidelines may need to be altered to
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recommend a minimum of 4 weeks of recovery time following TBI to promote an
improved outcome [223].
4. Discussion
Recently, there has been increased public awareness regarding the long-term
consequences of repetitive TBI and its role in the pathogenesis of CTE. A history of
concussions may not be necessary for the development of the neurodegenerative disorder,
but the pathophysiological changes associated with brain injury are clearly important.
The biomechanical forces responsible for TBI can produce diffuse axonal injury,
excitotoxicity, microglial activation, and cerebrovascular compromise. Repetitive injury
can result in prolonged activation of these neurodegenerative mechanisms, which can
produce the hyperphosphorylated tau and TDP-43 accumulations associated with CTE.
However, more research will be necessary to provide further evidence for this theory.
CTE research is still in its infancy, and thus, scientific knowledge of the disorder
is still limited. The disease was only recently found to affect a much broader population
than just boxers. Hence, it is more important than ever to increase understanding of CTE
to reduce the potential negative impact on society. Much progress has been made in the
last few years, but more work still needs to be done. Hopefully, with further research,
scientists and clinicians will be able to accurately define the clinical and neuropathologic
diagnostic criteria.
To date, there have been no randomized neuropathological studies, which created
a selection bias among studies. This has resulted in a large proportion of athletes
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diagnoses, which may not be representative of the epidemiology of the disease. CTE
potentially effects a much broader population. It will be necessary to design prospective
studies to elucidate the epidemiology and etiologies of the disorder, including the severity
and frequency of hits necessary for disease development, genetic predisposition, and
other associated risk factors. Researchers should make use of the knowledge available for
related neurodegenerative disorders to increase understanding. Better knowledge of these
risk factors will help to provide improved treatment and prevention.
Finally, more work is necessary to improve the neuroimaging and neurochemical
techniques presented in this review, so that the disease may be diagnosed in vivo. If this
becomes a possibility, there is a large window of opportunity for potential therapies to
slow or even stop the neurodegenerative disease progression. The earlier a patient is
diagnosed, the better effect interventions may have.
5. Conclusion
Concussions and mTBI appear to initiate lasting neurophysiological changes in
the injured brain, which can result in CTE development later in life. While other risk
factors are necessary, a history of repetitive brain trauma is the most highly correlated
event associated with disease pathogenesis. However, much more research will be
necessary to further elucidate this idea.
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